GLP-1 drugs work by enhancing insulin secretion, slowing gastric emptying, and sending signals to the brain to promote a feeling of fullness
Tamoxifen, a selective estrogen receptor modulator (SERM), has been associated with changes in fat distribution and metabolic slowing, potentially leading to gradual but significant weight gain over time
This study should be considered in any honest assessment of body composition claims
(Note, some iterations of semaglutide are currently in shortage)
However, if you miss more than two consecutive periods or experience severe symptoms, contact your PlexusDx provider or primary care doctor to rule out other medical causes
Efficacy and safety of lixisenatide in a predominantly asian population with type 2 diabetes insufficiently controlled with basal insulin: the getgoal-L-C randomized trial